Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years

Abstract

Active surveillance is a viable option in select men younger than 60 years with low volume, low risk prostate cancer. However, patients must be surveyed closely and understand the significant likelihood of ultimately requiring treatment.